#news #biotech JPM: Boehringer inks Enara deal to source ‘dark antigens’ for cancer immunotherapies

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: JPM: Boehringer inks Enara deal to source ‘dark antigens’ for cancer immunotherapies .JPM: Boehringer inks Enara deal to source ‘dark antigens’ for cancer immunotherapies
ntaylor
Tue, 01/12/2021 – 04:03

from FierceBiotech: Biotech https://ift.tt/3nDT5v6